These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10524451)

  • 1. Serum soluble CD44 in pediatric patients with acute leukemia.
    Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
    J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
    Ahmed MI; Hassab HM
    Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
    Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
    Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
    Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
    Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
    Amirghofran Z; Asiaee E; Kamazani FM
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium.
    Spertini O; Callegari P; Cordey AS; Hauert J; Joggi J; von Fliedner V; Schapira M
    Blood; 1994 Aug; 84(4):1249-56. PubMed ID: 7519478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1999 Dec; 17(4):161-8. PubMed ID: 10725871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
    Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of polychemotherapy on hemopoiesis in acute lymphoblastic leukemia in children].
    Vladimirskaia EB; Zamarraeva NV; Lebedev VV; Kryzhanovskiĭ OI; Rumiantsev AG; Sallakh S; Tabet S; Mazo IB
    Gematol Transfuziol; 1993 May; 38(5):6-10. PubMed ID: 8034176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
    Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.
    Stahnke K; Eckhoff S; Mohr A; Meyer LH; Debatin KM
    Leukemia; 2003 Nov; 17(11):2130-9. PubMed ID: 14523471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Iijima K
    Leuk Res; 2002 Mar; 26(3):241-8. PubMed ID: 11792412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of acute leukemia with drug combinations which include asparaginase.
    Leventhal BG; Henderson ES
    Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of relapsed AML and ALL].
    Nishikawa K
    Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
    Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia in Ehlers-Danlos syndrome.
    Asano T; Yamamoto M
    Int J Hematol; 1996 Oct; 64(3-4):283-5. PubMed ID: 8923793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.